Journal of Neuro-Oncology

, Volume 116, Issue 3, pp 515–522 | Cite as

Does the existence of HCMV components predict poor prognosis in glioma?

  • Daling Ding
  • Sheng Han
  • Zixun Wang
  • Zongze Guo
  • Anhua Wu
Laboratory Investigation

Abstract

Human cytomegalovirus (HCMV) has been associated with malignant gliomas. The objective of the present study was to further investigate the existence and prognostic value of HCMV components in gliomas. Using immunohistochemical staining, HCMV proteins IE1-72 and pp65 were examined in 67 glioma specimens of various histologic grades, in comparison to 6 -control brain tissue samples. The HCMV DNA was measured in both the tumor tissues and the peripheral blood of the patients, using nested PCR. Kaplan–Meier analysis and Cox proportional hazards models were used to analyzed the prognostic value of HCMV components in glioma tissues. IE1-72 was detected in 76.1 % (51/67) of glioma tissues, and pp65 was detected in 65.7 % (44/67) of glioma tissues. HCMV DNA was detected in 52.2 % (35/67) of glioma tissues and 29.9 % (20/67) of peripheral blood samples of glioma patients. These HCMV components were not detected in control brain tissue. However, the existence of HCMV components showed no significant correlation with the prognosis of glioma patients. Our results demonstrate that although HCMV proteins and nucleic acids are present in gliomas, they do not correlate with the prognosis. The role of HCMV in gliomas needs to be carefully interpreted.

Keywords

Gliomas Human cytomegalovirus Prognosis 

References

  1. 1.
    Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996PubMedCrossRefGoogle Scholar
  2. 2.
    Cobbs CS (2011) Evolving evidence implicates cytomegalovirus as a promoter of malignant glioma pathogenesis. Herpesviridae 2:10PubMedCentralPubMedCrossRefGoogle Scholar
  3. 3.
    Zur HH (2009) The search for infectious causes of human cancers: where and why. Virology 392:1–10CrossRefGoogle Scholar
  4. 4.
    Alibek K, Kakpenova A, Baiken Y (2013) Role of infectious agents in the carcinogenesis of brain and head and neck cancers. Infect Agent Cancer 8:7PubMedCentralPubMedCrossRefGoogle Scholar
  5. 5.
    Are C, Rajaram S, Are M, Raj H, Anderson BO, Chaluvarya SR, Vijayakumar M, Song T, Pandey M, Edney JA, Cazap EL (2013) A review of global cancer burden: trends, challenges, strategies, and a role for surgeons. J Surg Oncol 107:221–226PubMedCrossRefGoogle Scholar
  6. 6.
    Scheurer ME, Bondy ML, Aldape KD, Albrecht T, El-Zein R (2008) Detection of human cytomegalovirus in different histological types of gliomas. Acta Neuropathol 116:79–86PubMedCentralPubMedCrossRefGoogle Scholar
  7. 7.
    Soderberg-Naucler C (2006) Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer. J Intern Med 259:219–246PubMedCrossRefGoogle Scholar
  8. 8.
    Cobbs CS, Harkins L, Samanta M, Gillespie GY, Bharara S, King PH, Nabors LB, Cobbs CG, Britt WJ (2002) Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res 62:3347–3350PubMedGoogle Scholar
  9. 9.
    Jarvis MA, Wang CE, Meyers HL, Smith PP, Corless CL, Henderson GJ, Vieira J, Britt WJ, Nelson JA (1999) Human cytomegalovirus infection of caco-2 cells occurs at the basolateral membrane and is differentiation state dependent. J Virol 73:4552–4560PubMedCentralPubMedGoogle Scholar
  10. 10.
    Kwok S, Higuchi R (1989) Avoiding false positives with PCR. Nature 339:237–238PubMedCrossRefGoogle Scholar
  11. 11.
    Esteller M, Hamilton SR, Burger PC, Baylin SB, Herman JG (1999) Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res 59:793–797PubMedGoogle Scholar
  12. 12.
    Mitchell DA, Xie W, Schmittling R, Learn C, Friedman A, McLendon RE, Sampson JH (2008) Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma. Neuro Oncol 10:10–18PubMedCentralPubMedCrossRefGoogle Scholar
  13. 13.
    Johnsen JI, Baryawno N, Soderberg-Naucler C (2011) Is human cytomegalovirus a target in cancer therapy. Oncotarget 2:1329–1338PubMedGoogle Scholar
  14. 14.
    Javier RT, Butel JS (2008) The history of tumor virology. Cancer Res 68:7693–7706PubMedCentralPubMedCrossRefGoogle Scholar
  15. 15.
    McLaughlin-Drubin ME, Munger K (2008) Viruses associated with human cancer. Biochim Biophys Acta 1782:127–150PubMedCentralPubMedCrossRefGoogle Scholar
  16. 16.
    Harkins L, Volk AL, Samanta M, Mikolaenko I, Britt WJ, Bland KI, Cobbs CS (2002) Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer. Lancet 360:1557–1563PubMedCrossRefGoogle Scholar
  17. 17.
    Samanta M, Harkins L, Klemm K, Britt WJ, Cobbs CS (2003) High prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carcinoma. J Urol 170:998–1002PubMedCrossRefGoogle Scholar
  18. 18.
    Prins RM, Cloughesy TF, Liau LM (2008) Cytomegalovirus immunity after vaccination with autologous glioblastoma lysate. N Engl J Med 359:539–541PubMedCentralPubMedCrossRefGoogle Scholar
  19. 19.
    Baryawno N, Rahbar A, Wolmer-Solberg N, Taher C, Odeberg J, Darabi A, Khan Z, Sveinbjornsson B, FuskevAg OM, Segerstrom L, Nordenskjold M, Siesjo P, Kogner P, Johnsen JI, Soderberg-Naucler C (2011) Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target. J Clin Invest 121:4043–4055PubMedCentralPubMedCrossRefGoogle Scholar
  20. 20.
    Melnick M, Sedghizadeh PP, Allen CM, Jaskoll T (2012) Human cytomegalovirus and mucoepidermoid carcinoma of salivary glands: cell-specific localization of active viral and oncogenic signaling proteins is confirmatory of a causal relationship. Exp Mol Pathol 92:118–125PubMedCrossRefGoogle Scholar
  21. 21.
    Lau SK, Chen YY, Chen WG, Diamond DJ, Mamelak AN, Zaia JA, Weiss LM (2005) Lack of association of cytomegalovirus with human brain tumors. Mod Pathol 18:838–843PubMedCrossRefGoogle Scholar
  22. 22.
    Sabatier J, Uro-Coste E, Pommepuy I, Labrousse F, Allart S, Tremoulet M, Delisle MB, Brousset P (2005) Detection of human cytomegalovirus genome and gene products in central nervous system tumours. Br J Cancer 92:747–750PubMedCentralPubMedCrossRefGoogle Scholar
  23. 23.
    Poltermann S, Schlehofer B, Steindorf K, Schnitzler P, Geletneky K, Schlehofer JR (2006) Lack of association of herpesviruses with brain tumors. J Neurovirol 12:90–99PubMedCrossRefGoogle Scholar
  24. 24.
    Dziurzynski K, Chang SM, Heimberger AB, Kalejta RF, McGregor DSR, Smit M, Soroceanu L, Cobbs CS (2012) Consensus on the role of human cytomegalovirus in glioblastoma. Neuro Oncol 14:246–255PubMedCentralPubMedCrossRefGoogle Scholar
  25. 25.
    Soroceanu L, Cobbs CS (2011) Is HCMV a tumor promoter. Virus Res 157:193–203PubMedCentralPubMedCrossRefGoogle Scholar
  26. 26.
    Hawkins C, Croul S (2011) Viruses and human brain tumors: cytomegalovirus enters the fray. J Clin Invest 121:3831–3833PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Daling Ding
    • 1
  • Sheng Han
    • 1
  • Zixun Wang
    • 1
  • Zongze Guo
    • 1
  • Anhua Wu
    • 1
  1. 1.Department of NeurosurgeryThe First Hospital of China Medical UniversityShenyangChina

Personalised recommendations